Feline Ureteral Obstruction (Ureterolithiasis)

Feline ureteral obstruction (ureterolithiasis) is a condition in which one or both ureters become partially or completely blocked, most commonly by calcium oxalate uroliths lodged within the ureteral lumen [1]. The condition has become increasingly recognized as a significant clinical problem in domestic cats, with the incidence continuing to rise in recent years [2]. Obstruction impairs urine flow from the kidney to the bladder, causing progressive ipsilateral hydronephrosis, renal pelvic dilation, and ultimately irreversible nephron loss if left untreated [1]. Because many affected cats have concurrent chronic kidney disease (CKD) or contralateral renal compromise, ureteral obstruction frequently constitutes a life-threatening emergency requiring prompt diagnosis and intervention [5].

Primary Causes

Ureterolithiasis (calculi) is overwhelmingly the most common cause of feline ureteral obstruction. Calcium oxalate uroliths account for the vast majority of feline ureteral stones; their hard crystalline structure and irregular surfaces make spontaneous passage difficult and predispose to mucosal injury and subsequent stricture formation [1][5]. The prevalence of calcium oxalate nephroliths and ureteroliths has increased substantially over recent decades, likely reflecting shifts in commercial diet composition, increased longevity of the cat population, and advances in diagnostic imaging that improve detection [5].

Ureteral strictures represent a distinct and underrecognized cause of obstruction. Strictures may develop secondary to prior urolith trauma, ureterotomy, ureteroscopy, or inflammatory processes, and may occur without any identifiable calculus [4]. In a case series of 10 cats with ureteral strictures, prior urolith disease or urinary tract instrumentation was identified as a predisposing factor in many cases [4].

Other reported causes include blood clots, inflammatory debris, neoplasia (primary ureteral or extrinsic compression), and fungal infections, though these are far less common than calculi [1].

Pathophysiological Mechanism

Once a calculus or other obstructing lesion becomes lodged—most commonly at the ureteropelvic junction (UPJ) or the ureterovesicular junction (UVJ), which are the narrowest points of the feline ureter—urine flow is impeded [1]. The feline ureter is particularly narrow (approximately 0.4 mm inner diameter), making passage of even small stones difficult [1][5].

Obstruction leads to a rapid rise in intraluminal ureteral and renal pelvic pressure. This elevated pressure triggers:

1. ·Renal pelvic and ureteral dilation (hydroureter/hydronephrosis) — progressive distension of the collecting system.
2. ·Decreased renal blood flow — vasoconstriction and ischemia lead to glomerular filtration rate (GFR) reduction on the affected side; in bilateral obstruction, systemic azotemia results.
3. ·Tubular injury and interstitial fibrosis — sustained pressure causes tubular atrophy and irreversible parenchymal loss; time-sensitive intervention is critical because the window for functional recovery narrows with the duration of obstruction [1][5].
4. ·Ureteral smooth muscle spasm — secondary to stone irritation and mucosal inflammation, perpetuating obstruction even when partial luminal patency might otherwise allow spontaneous passage [1][2].

Alpha-1 adrenergic receptors in the ureteral smooth muscle mediate much of this spasm, providing the rationale for alpha-blocker therapy (e.g., tamsulosin) to facilitate stone passage [2][3]. Concurrent bacterial pyelonephritis may develop secondary to urinary stasis, further compounding renal injury [5].

Clinical and Physical Examination

Cats are typically presented for acute vomiting, lethargy, and anorexia. Physical examination may reveal renomegaly (hydronephrosis), renal pain, dehydration, and sometimes hypothermia in severely azotemic animals [1][2]. A thorough palpation of the kidneys and mid-abdomen is essential, though pain may limit the examination.

Laboratory Findings

Laboratory evaluation is critical to assess the severity of renal compromise and to guide urgency of intervention:

• ·Serum creatinine (CREA) and blood urea nitrogen (BUN): Often markedly elevated, reflecting reduced GFR from obstruction ± underlying CKD. Degree of azotemia helps gauge severity [2][3]. In one study evaluating outcomes of tamsulosin therapy, mean serum creatinine at presentation was significantly elevated in non-responders [2].
• ·Hematocrit (HCT): Non-regenerative anemia is common in cats with concurrent CKD; conversely, dehydration may artificially elevate PCV on initial presentation [2].
• ·Electrolytes: Hyperkalemia and hyperphosphatemia may accompany severe acute kidney injury, particularly with bilateral or complete obstruction; these represent life-threatening metabolic emergencies [1].
• ·Serum albumin (ALB): May be low in cats with chronic disease and poor nutritional status, affecting drug pharmacokinetics and overall prognosis [2].
• ·ALT and liver enzymes: Generally normal unless hepatic involvement or secondary hepatic lipidosis is present.
• ·Urinalysis and urine culture: Pyuria, hematuria, and bacteriuria may indicate concurrent urinary tract infection or pyelonephritis. Urine culture is important to direct antibiotic therapy [5].
• ·Urine specific gravity: Often isosthenuric in cats with significant renal impairment from obstruction.
• ·Complete blood count (CBC): Leukocytosis (elevated WBC) may signal concurrent pyelonephritis or systemic inflammatory response; thrombocytopenia (low PLT) can occur in severe systemic illness [2].
• ·Phosphorus (PHOS): Hyperphosphatemia parallels severity of azotemia and degree of renal functional compromise.

Diagnostic Imaging

Imaging is the cornerstone of diagnosis and is required to confirm obstruction, characterize its cause and location, assess the degree of hydronephrosis, and plan intervention:

• ·Abdominal radiography: Plain radiographs can identify radiopaque calcium oxalate uroliths in the ureteral course, though small stones may be missed and soft-tissue obstructions are not visible [1][5].
• ·Abdominal ultrasonography: The primary imaging modality; reveals hydronephrosis (pelvic dilation ≥ 13 mm is associated with more severe obstruction), ureteral dilation, and can often identify the obstructing calculus or site of stricture [1][2][5]. Renal cortical echogenicity and thickness provide information about chronicity of injury.
• ·Computed tomography (CT) with or without contrast: Considered the gold standard for detecting and localizing ureteroliths in human medicine and increasingly used in veterinary referral settings; superior sensitivity for small stones, stricture delineation, and assessment of obstruction degree [1][5].
• ·Intravenous pyelography (IVP) / antegrade pyelography: May demonstrate lack of ureteral opacification distal to the obstruction and confirm complete versus partial blockage; increasingly supplanted by CT but still used in some settings [1].
• ·Nuclear scintigraphy: Can quantify the split GFR of each kidney individually, which helps assess functional contribution of the affected kidney and guides therapeutic decision-making [1].

Management of feline ureteral obstruction requires individualized decision-making based on the severity of azotemia, number of kidneys affected, duration of obstruction, stone size and location, and availability of interventional expertise. Options range from medical management to minimally invasive procedures and open surgery [1].

1. Stabilization and Supportive Care

All patients should receive:

• ·Intravenous fluid therapy to correct dehydration, address prerenal azotemia, and promote diuresis
• ·Correction of electrolyte abnormalities — hyperkalemia requires immediate treatment (insulin/dextrose, calcium gluconate, sodium bicarbonate) [1]
• ·Anti-emetics (e.g., maropitant) for vomiting
• ·Nutritional support in debilitated cats
• ·Antibiotics if concurrent pyelonephritis is suspected, guided by urine culture results [5]

2. Medical Management (Ureteral Relaxation Therapy)

Spontaneous stone passage is uncommon in cats due to the small ureteral diameter, yet a subset of cats—particularly those with small calculi—may respond to medical management [1][2][3].

Tamsulosin (alpha-1 adrenergic receptor antagonist): Relaxes ureteral smooth muscle, potentially facilitating spontaneous stone passage. Based on its established use in human urology, tamsulosin has been evaluated in cats as an extra-label treatment:

• ·In a retrospective study of 70 cats with obstructive ureteral stones treated with tamsulosin, the response rate (defined as stone passage or obstruction resolution) was reported, with smaller stone size and less severe azotemia at presentation being favorable predictive factors [2].
• ·A single-center retrospective study also confirmed that tamsulosin-based medical treatment could be effective in a proportion of cats with multi-causal ureteral obstruction, and identified clinicopathological factors influencing response [3].
• ·Medical management is generally reserved for cats with partial obstruction, small stone size, and clinically stable azotemia, with close monitoring for clinical deterioration requiring prompt escalation [2][3].

Fluid diuresis: High-volume IV fluid administration may help "flush" small calculi through the ureter by increasing urine flow rate [1].

Glucocorticoids and anti-inflammatories: Sometimes used to reduce periureteral inflammation and edema, though evidence in cats is limited [1].

3. Interventional (Minimally Invasive) Procedures

Minimally invasive endourological techniques, well-established in human urology, have been adapted for cats at specialized referral centers [1]:

a. Ureteral Stenting (Double-Pigtail Stent)

A soft 2.5 Fr double-pigtail stent is placed to bypass the obstruction, maintaining ureteral patency and allowing the obstructed kidney to drain while the stone either passes spontaneously or is managed definitively [1][6][7].

• ·Placement can be performed via a fluoroscopic/cystoscopic approach (antegrade or retrograde) or surgically assisted [7].
• ·In a retrospective study comparing stents and ureteral bypass (UB) devices in cats, both modalities resulted in improvement in renal parameters, though complication profiles differed between groups [6].
• ·In a series of 15 cases (12 cats), stenting—combined or not with ureterotomy—resulted in improvement in renal function in the majority; however, stent-associated complications (migration, re-obstruction, lower urinary tract signs) were noted [7].
• ·Stent exchange may be necessary every 6–12 months due to encrustation [1][6].

b. Subcutaneous Ureteral Bypass (SUB) Device

The SUB device creates an indwelling subcutaneous shunt from the renal pelvis to the bladder, bypassing the ureter entirely [1][6].

• ·Comparison studies demonstrate that the SUB device may have certain advantages over ureteral stents, including lower rates of re-obstruction in some series, though device-related complications (UTI, device occlusion, kinking) remain a concern [6].
• ·Both stents and SUB devices require long-term follow-up, periodic flushing, and possible re-intervention [6].

c. Extracorporeal Shockwave Lithotripsy (ESWL)

ESWL uses focused acoustic shock waves to fragment ureteroliths into smaller pieces that may pass spontaneously. While widely used in human urology, its application in cats is limited by the small ureteral diameter and concerns about tissue damage [1][5].

4. Surgical Management

Traditional open surgical approaches include:

• ·Ureterotomy: Incision into the ureter to remove the obstructing calculus; carries risk of post-operative stricture formation at the surgical site and is associated with significant complication rates in cats [1][5].
• ·Ureteral reimplantation (neoureterocystostomy): Resection of the affected ureteral segment and reimplantation into the bladder; used for distal ureteral strictures or irreparable obstruction [1][4].
• ·Ureteronephrectomy: Removal of the affected kidney and ureter; reserved for cases where the kidney is non-functional and no recovery is expected, or when infection cannot be controlled [1].
• ·Pyelostomy / nephrostomy tube placement: Temporary decompression of the obstructed collecting system, used as a bridge to definitive treatment [1].

Surgery remains an option, particularly in centers without interventional endourology expertise, but the risk of ureteral stricture as a post-operative complication is a major concern in cats, given the delicate and narrow feline ureter [1][4][5].

The prognosis for feline ureteral obstruction is guarded to fair and is heavily influenced by the severity and duration of obstruction, degree of azotemia at presentation, the functional status of the contralateral kidney, and the success of decompressive intervention.

Short-Term Outcomes

• ·Cats with complete bilateral obstruction or obstruction of a solitary functional kidney are in a critical state; without prompt intervention, death from uremia is expected [1].
• ·Perioperative and early post-operative mortality is a recognized risk with all interventional approaches. In a study of double-pigtail stents versus SUB devices, perioperative complications were identified in both groups, and survival to discharge was not universally achieved [6].
• ·In the stent series reported by Manassero et al. (2014), the majority of cats showed improvement in renal parameters following stenting, though some cats died or were euthanized in the peri-procedural period due to severe azotemia or complications [7].

Response to Medical Management

• ·In the retrospective study by Chae et al. (2022) evaluating tamsulosin in 70 cats, smaller stone size and less severe renal dysfunction at presentation were significantly associated with successful stone passage; cats that failed medical treatment required escalation to interventional or surgical management [2].
• ·Furusawa et al. (2026) further confirmed that a subset of cats with multi-causal obstruction responded to tamsulosin-based medical treatment, with clinicopathological factors (including degree of hydronephrosis and creatinine level) predicting response [3].

Long-Term Prognosis

• ·Long-term prognosis is significantly impacted by the degree of irreversible renal damage sustained before obstruction was relieved; early intervention is associated with better functional recovery [1][5].
• ·Cats that survive the acute event and in which ureteral patency is restored often have residual CKD, requiring long-term medical management, dietary modification, and monitoring [5].
• ·Ureteral strictures carry a guarded long-term prognosis; in the series of 10 cats reported by Zaid et al. (2011), outcomes varied depending on treatment modality, with some cats requiring multiple interventions and others having prolonged survival [4].
• ·Stent- and SUB-related complications (re-obstruction, device migration, ascending infections) necessitate ongoing surveillance, and some cats require re-intervention months to years after initial treatment [6][7].
• ·Overall, with prompt and appropriate management at referral centers with endourological expertise, survival rates and renal functional outcomes have improved compared to historical open-surgical approaches, though definitive long-term survival statistics across large populations remain limited in the current veterinary literature [1][6].

There are currently no vaccines for feline ureteral obstruction. Prevention strategies focus on minimizing the risk of urolith formation and recurrence, particularly of calcium oxalate uroliths, and on early detection of renal and urinary tract disease.

Dietary Management

• ·Increased water intake: Promoting hydration through feeding wet (canned) food, use of water fountains, and multiple water stations helps dilute urine and reduce supersaturation with calculogenic minerals [5].
• ·Dissolution and prevention diets: While calcium oxalate uroliths cannot be dissolved medically (unlike struvite), maintenance of urine pH in a slightly acidic to neutral range and restriction of dietary oxalate and sodium are recommended strategies [5].
• ·Urinary modification diets: Prescription diets formulated to reduce urinary calcium oxalate relative supersaturation may reduce recurrence risk in cats with prior urolith disease [5].

Medical Prophylaxis

• ·Potassium citrate: Increases urinary citrate, which complexes with calcium and inhibits calcium oxalate crystal formation; may be used in cats with recurrent calcium oxalate urolithiasis [5].
• ·Hydrochlorothiazide: Reduces urinary calcium excretion; occasionally used in cats with hypercalciuria predisposing to calcium oxalate uroliths, though evidence-based protocols in cats are limited [5].

Monitoring and Early Detection

• ·Regular urinalysis and urine culture: Early detection of crystalluria, infection, and changes in urine pH can allow timely dietary or medical adjustment before stones develop or worsen [5].
• ·Periodic renal imaging: Cats with a history of ureterolithiasis, nephrolithiasis, or CKD should have periodic abdominal ultrasonography to monitor for new stone formation or ureteral dilation, enabling early intervention before complete obstruction occurs [1][5].
• ·Management of underlying conditions: Cats with hypercalcemia (e.g., from idiopathic hypercalcemia or neoplasia) have an increased risk of calcium oxalate urolithiasis; addressing the underlying cause may reduce stone formation [5].

Post-Intervention Follow-Up

• ·Cats that have undergone ureteral stenting or SUB device placement require scheduled device monitoring (including fluoroscopic evaluation) and periodic flushing of devices to prevent occlusion and reduce infection risk [6][7].
• ·All cats treated for ureteral obstruction should receive lifelong CKD management and regular veterinary monitoring given the high likelihood of underlying or residual renal disease [5].